Updates are available Correction dated 2025-05-16
Click to view Correction: https://doi.org/10.1038/s41419-025-07628-7
-
Authors
Wang, Shujie
Zhang, Tongjia
Zhou, Yue
Jiao, Zitao
Lu, Kejia
Liu, Xinyi
Jiang, Wei
Yang, Zhe
Li, Hui
Zhang, Xiaowei https://orcid.org/0000-0001-7280-2844
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82372892)
- License Information
-
More Information
Article History
Received: 20 August 2024
Revised: 19 December 2024
Accepted: 24 January 2025
First Online: 5 February 2025
Change Date: 18 April 2025
Change Type: Update
Change Details: The original online version of this article was revised: During the assembly of the figure 6F, the migration image for the sorafenib+GP73 condition was inadvertently misused.
Change Date: 16 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41419-025-07628-7
Competing interests
: The authors declare no competing interests.
: The study for mice is compliant with all relevant ethical regulations for animal experiments. All experiments and facilities were approved by the Committee for Ethics of Animal Experiments and were conducted in conformity to the Guidelines for Animal Experiments, Peking University Health Science Center (LA2020230).
